
UNH
- Market cap
- $472B
- Sector
- Health care

7 8-Ks, 5 10-Qs, 1 DEF 14A and 1 10-K
Risk factors and management’s discussion, each against the previous 10-K
Changes against the prior filing graded material rather than notable or routine
Carried as absent in the model rather than as last quarter’s number
UnitedHealth's annual report, 156 pages. Revenue is $442.8 billion, up 3.3% on the prior year, at an operating margin of 6.2%. The risk section names funding and leverage as a risk of its own for the first time, and the discussion attributes the year's margin to the mix of its own lines rather than to one change.
Changes against the prior filing
| Section | Materiality | What changed |
|---|---|---|
| Item 1A — Risk factors | material | Funding and leverage are named as a risk of their own: $82.0 billion of borrowings against $34.0 billion of cash and investments. |
| Item 7 — Management's discussion | notable | The operating margin is stated at 6.2%, against 6.1% a year earlier, and revenue is up 3.3% on the prior year. |
| Item 7A — Market risk | notable | The interest-rate sensitivity of the borrowings is disclosed against a 100 basis point move, where it was previously 50. |
| Item 5 — Equity and repurchases | routine | The diluted share count is 0.92 billion, against 0.93 billion a year earlier. |
Risk factors added and removed
New
Removed
Stated figures
Unquantified claims
Model impact
| Driver | Reason | From | To | Value per share |
|---|---|---|---|---|
| Operating margin, base period | The base period rolled forward to the trailing twelve months, so the ramp now starts from the margin the company has just earned rather than the one it earned a year ago. | 6.1% | 6.2% | +$1.86 |
| Consensus revenue growth | The forward growth used in the projection tracks the published consensus for the next two fiscal years, and the consensus moved. | 4.6% | 5.2% | +$6.15 |
Where this reading came from
Written by sentiment-edgar-risk-analysis 2.1.0, 1 Feb 2026.
Updated 1 Feb 2026
| Form | Period | Filed | Accession number | Reading | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8-K | no reporting period — an event report | 14 Aug 2026 | 0000731766-26-000102 | Read | |||||||||||||||||||||||||||
UnitedHealth's 8-K for the period, 4 pages. Revenue over the trailing twelve months is $442.8 billion, up 3.3% on the prior year, at an operating margin of 6.2%. No written analysis has been produced for this document: the extraction covers the subject's filings first, and everything below is read off the accounts rather than out of the text. Changes against the prior filing
Risk factors added and removed No risk factor was added or removedThe comparison against the prior document returned neither an addition nor a removal. Stated figures Revenue, trailing twelve months$442.8bn Operating income$27.45bn Free cash flow$21.57bn Diluted shares0.92bn Unquantified claims
Model impact No model impactNothing it states changed an input the valuation reads. A filing can be worth reading and change no figure — the changes above are still the record of what it said. Where this reading came from Written by sentiment-edgar-risk-analysis 2.1.0, 14 Aug 2026. Updated 14 Aug 2026 | |||||||||||||||||||||||||||||||
10-Q | period ended 30 Jun 2026 | 16 Jul 2026 | 0000731766-26-000093 | Read | |||||||||||||||||||||||||||
UnitedHealth's quarterly report, 68 pages. Revenue is $442.8 billion, up 3.3% on the prior year, at an operating margin of 6.2%. The interim discussion repeats the guidance given with the results and adds no phasing for the second half. Changes against the prior filing
Risk factors added and removed No risk factor was added or removedThe comparison against the prior document returned neither an addition nor a removal. Stated figures Revenue, trailing twelve months$442.8bn Operating income$27.45bn Operating margin6.2% Free cash flow$21.57bn Total debt$82.0bn Diluted shares0.92bn Unquantified claims
Model impact
Where this reading came from Written by sentiment-edgar-risk-analysis 2.1.0, 16 Jul 2026. Updated 16 Jul 2026 | |||||||||||||||||||||||||||||||
8-K | no reporting period — an event report | 15 Jul 2026 | 0000731766-26-000084 | Read | |||||||||||||||||||||||||||
UnitedHealth's quarterly results release, filed with the press release as Exhibit 99.1. Revenue is $442.8 billion, up 3.3% on the prior year, at an operating margin of 6.2%. It carries the results and the reconciliation tables and nothing else: no agreement, no officer change, no impairment. Changes against the prior filing
Risk factors added and removed No risk factor was added or removedThe comparison against the prior document returned neither an addition nor a removal. Stated figures Revenue, trailing twelve months$442.8bn Operating income$27.45bn Operating margin6.2% Free cash flow$21.57bn Total debt$82.0bn Diluted shares0.92bn Unquantified claims
Model impact
Where this reading came from Written by sentiment-edgar-release-analysis 0.4.0, 15 Jul 2026. Updated 15 Jul 2026 | |||||||||||||||||||||||||||||||
8-K | no reporting period — an event report | 10 May 2026 | 0000731766-26-000075 | Read | |||||||||||||||||||||||||||
UnitedHealth's 8-K for the period, 5 pages. Revenue over the trailing twelve months is $442.8 billion, up 3.3% on the prior year, at an operating margin of 6.2%. No written analysis has been produced for this document: the extraction covers the subject's filings first, and everything below is read off the accounts rather than out of the text. Changes against the prior filing
Risk factors added and removed No risk factor was added or removedThe comparison against the prior document returned neither an addition nor a removal. Stated figures Revenue, trailing twelve months$442.8bn Operating income$27.45bn Free cash flow$21.57bn Diluted shares0.92bn Unquantified claims
Model impact No model impactNothing it states changed an input the valuation reads. A filing can be worth reading and change no figure — the changes above are still the record of what it said. Where this reading came from Written by sentiment-edgar-risk-analysis 2.1.0, 10 May 2026. Updated 10 May 2026 | |||||||||||||||||||||||||||||||
10-Q | period ended 31 Mar 2026 | 16 Apr 2026 | 0000731766-26-000066 | Read | |||||||||||||||||||||||||||
UnitedHealth's 10-Q for the period, 57 pages. Revenue over the trailing twelve months is $442.8 billion, up 3.3% on the prior year, at an operating margin of 6.2%. No written analysis has been produced for this document: the extraction covers the subject's filings first, and everything below is read off the accounts rather than out of the text. Changes against the prior filing
Risk factors added and removed No risk factor was added or removedThe comparison against the prior document returned neither an addition nor a removal. Stated figures Revenue, trailing twelve months$442.8bn Operating income$27.45bn Free cash flow$21.57bn Diluted shares0.92bn Unquantified claims
Model impact No model impactNothing it states changed an input the valuation reads. A filing can be worth reading and change no figure — the changes above are still the record of what it said. Where this reading came from Written by sentiment-edgar-risk-analysis 2.1.0, 16 Apr 2026. Updated 16 Apr 2026 | |||||||||||||||||||||||||||||||
8-K | no reporting period — an event report | 15 Apr 2026 | 0000731766-26-000057 | Read | |||||||||||||||||||||||||||
UnitedHealth's 8-K for the period, 3 pages. Revenue over the trailing twelve months is $442.8 billion, up 3.3% on the prior year, at an operating margin of 6.2%. No written analysis has been produced for this document: the extraction covers the subject's filings first, and everything below is read off the accounts rather than out of the text. Changes against the prior filing
Risk factors added and removed No risk factor was added or removedThe comparison against the prior document returned neither an addition nor a removal. Stated figures Revenue, trailing twelve months$442.8bn Operating income$27.45bn Free cash flow$21.57bn Diluted shares0.92bn Unquantified claims
Model impact No model impactNothing it states changed an input the valuation reads. A filing can be worth reading and change no figure — the changes above are still the record of what it said. Where this reading came from Written by sentiment-edgar-risk-analysis 2.1.0, 15 Apr 2026. Updated 15 Apr 2026 | |||||||||||||||||||||||||||||||
DEF 14A | no reporting period — an event report | 7 Apr 2026 | 0000731766-26-000048 | Read | |||||||||||||||||||||||||||
UnitedHealth's DEF 14A for the period, 82 pages. Revenue over the trailing twelve months is $442.8 billion, up 3.3% on the prior year, at an operating margin of 6.2%. No written analysis has been produced for this document: the extraction covers the subject's filings first, and everything below is read off the accounts rather than out of the text. Changes against the prior filing
Risk factors added and removed No risk factor was added or removedThe comparison against the prior document returned neither an addition nor a removal. Stated figures Revenue, trailing twelve months$442.8bn Operating income$27.45bn Free cash flow$21.57bn Diluted shares0.92bn Unquantified claims
Model impact No model impactNothing it states changed an input the valuation reads. A filing can be worth reading and change no figure — the changes above are still the record of what it said. Where this reading came from Written by sentiment-edgar-risk-analysis 2.1.0, 7 Apr 2026. Updated 7 Apr 2026 | |||||||||||||||||||||||||||||||
10-K | period ended 31 Dec 2025 | 1 Feb 2026 | 0000731766-26-000039 | Read | |||||||||||||||||||||||||||
Its reading leads this page, under Latest 10-K reading. | |||||||||||||||||||||||||||||||
8-K | no reporting period — an event report | 15 Jan 2026 | 0000731766-26-000030 | Read | |||||||||||||||||||||||||||
UnitedHealth's 8-K for the period, 9 pages. Revenue over the trailing twelve months is $442.8 billion, up 3.3% on the prior year, at an operating margin of 6.2%. No written analysis has been produced for this document: the extraction covers the subject's filings first, and everything below is read off the accounts rather than out of the text. Changes against the prior filing
Risk factors added and removed No risk factor was added or removedThe comparison against the prior document returned neither an addition nor a removal. Stated figures Revenue, trailing twelve months$442.8bn Operating income$27.45bn Free cash flow$21.57bn Diluted shares0.92bn Unquantified claims
Model impact No model impactNothing it states changed an input the valuation reads. A filing can be worth reading and change no figure — the changes above are still the record of what it said. Where this reading came from Written by sentiment-edgar-risk-analysis 2.1.0, 15 Jan 2026. Updated 15 Jan 2026 | |||||||||||||||||||||||||||||||
10-Q | period ended 30 Sep 2025 | 16 Oct 2025 | 0000731766-25-000058 | Read | |||||||||||||||||||||||||||
UnitedHealth's 10-Q for the period, 54 pages. Revenue over the trailing twelve months is $442.8 billion, up 3.3% on the prior year, at an operating margin of 6.2%. No written analysis has been produced for this document: the extraction covers the subject's filings first, and everything below is read off the accounts rather than out of the text. Changes against the prior filing
Risk factors added and removed No risk factor was added or removedThe comparison against the prior document returned neither an addition nor a removal. Stated figures Revenue, trailing twelve months$442.8bn Operating income$27.45bn Free cash flow$21.57bn Diluted shares0.92bn Unquantified claims
Model impact No model impactNothing it states changed an input the valuation reads. A filing can be worth reading and change no figure — the changes above are still the record of what it said. Where this reading came from Written by sentiment-edgar-risk-analysis 2.1.0, 16 Oct 2025. Updated 16 Oct 2025 | |||||||||||||||||||||||||||||||
8-K | no reporting period — an event report | 15 Oct 2025 | 0000731766-25-000049 | Read | |||||||||||||||||||||||||||
UnitedHealth's 8-K for the period, 3 pages. Revenue over the trailing twelve months is $442.8 billion, up 3.3% on the prior year, at an operating margin of 6.2%. No written analysis has been produced for this document: the extraction covers the subject's filings first, and everything below is read off the accounts rather than out of the text. Changes against the prior filing
Risk factors added and removed No risk factor was added or removedThe comparison against the prior document returned neither an addition nor a removal. Stated figures Revenue, trailing twelve months$442.8bn Operating income$27.45bn Free cash flow$21.57bn Diluted shares0.92bn Unquantified claims
Model impact No model impactNothing it states changed an input the valuation reads. A filing can be worth reading and change no figure — the changes above are still the record of what it said. Where this reading came from Written by sentiment-edgar-risk-analysis 2.1.0, 15 Oct 2025. Updated 15 Oct 2025 | |||||||||||||||||||||||||||||||
10-Q | period ended 30 Jun 2025 | 16 Jul 2025 | 0000731766-25-000040 | Read | |||||||||||||||||||||||||||
UnitedHealth's 10-Q for the period, 71 pages. Revenue over the trailing twelve months is $442.8 billion, up 3.3% on the prior year, at an operating margin of 6.2%. No written analysis has been produced for this document: the extraction covers the subject's filings first, and everything below is read off the accounts rather than out of the text. Changes against the prior filing
Risk factors added and removed No risk factor was added or removedThe comparison against the prior document returned neither an addition nor a removal. Stated figures Revenue, trailing twelve months$442.8bn Operating income$27.45bn Free cash flow$21.57bn Diluted shares0.92bn Unquantified claims
Model impact No model impactNothing it states changed an input the valuation reads. A filing can be worth reading and change no figure — the changes above are still the record of what it said. Where this reading came from Written by sentiment-edgar-risk-analysis 2.1.0, 16 Jul 2025. Updated 16 Jul 2025 | |||||||||||||||||||||||||||||||
8-K | no reporting period — an event report | 15 Jul 2025 | 0000731766-25-000031 | Read | |||||||||||||||||||||||||||
UnitedHealth's 8-K for the period, 10 pages. Revenue over the trailing twelve months is $442.8 billion, up 3.3% on the prior year, at an operating margin of 6.2%. No written analysis has been produced for this document: the extraction covers the subject's filings first, and everything below is read off the accounts rather than out of the text. Changes against the prior filing
Risk factors added and removed No risk factor was added or removedThe comparison against the prior document returned neither an addition nor a removal. Stated figures Revenue, trailing twelve months$442.8bn Operating income$27.45bn Free cash flow$21.57bn Diluted shares0.92bn Unquantified claims
Model impact No model impactNothing it states changed an input the valuation reads. A filing can be worth reading and change no figure — the changes above are still the record of what it said. Where this reading came from Written by sentiment-edgar-risk-analysis 2.1.0, 15 Jul 2025. Updated 15 Jul 2025 | |||||||||||||||||||||||||||||||
10-Q | period ended 31 Mar 2025 | 16 Apr 2025 | 0000731766-25-000022 | Read | |||||||||||||||||||||||||||
UnitedHealth's 10-Q for the period, 62 pages. Revenue over the trailing twelve months is $442.8 billion, up 3.3% on the prior year, at an operating margin of 6.2%. No written analysis has been produced for this document: the extraction covers the subject's filings first, and everything below is read off the accounts rather than out of the text. Changes against the prior filing
Risk factors added and removed No risk factor was added or removedThe comparison against the prior document returned neither an addition nor a removal. Stated figures Revenue, trailing twelve months$442.8bn Operating income$27.45bn Free cash flow$21.57bn Diluted shares0.92bn Unquantified claims
Model impact No model impactNothing it states changed an input the valuation reads. A filing can be worth reading and change no figure — the changes above are still the record of what it said. Where this reading came from Written by sentiment-edgar-risk-analysis 2.1.0, 16 Apr 2025. Updated 16 Apr 2025 | |||||||||||||||||||||||||||||||